Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 202-255-5 | CAS number: 93-53-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Repeated dose toxicity: oral
Administrative data
- Endpoint:
- chronic toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Data is from peer reviewed journal
Data source
Reference
- Reference Type:
- publication
- Title:
- Short-term toxicity of hydratropic aldehyde in rats
- Author:
- Pelling D,Gaunt If ,Butterworth Kr ,Hardy J ,Lansdown A Bg ,Gangolli Sd
- Year:
- 1 976
- Bibliographic source:
- Fd Cosmet. Toxicol. Vol. 14. pp. 249-253, 1976
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- other: as mentioned below
- Principles of method if other than guideline:
- Repeated dose toxicity test was performed on rats for 15 weeks with different concentrations as 0 (control), 10, 50 or 500 mg/kg body weight/day.
- GLP compliance:
- no
- Limit test:
- no
Test material
- Reference substance name:
- Hydratropaldehyde
- EC Number:
- 202-255-5
- EC Name:
- Hydratropaldehyde
- Cas Number:
- 93-53-8
- Molecular formula:
- C9H10O
- IUPAC Name:
- hydratropaldehyde
- Details on test material:
- - Name of test material: Hydratropaldehyde- Molecular formula: C9H10O- Molecular weight: 134.17 g/mol- Smiles notation: CC(C=O)C1=CC=CC=C1- Substance type: Liquid- Physical state: Organic- Impurities (identity and concentrations): No data- Purity: minimum 98%
Constituent 1
Test animals
- Species:
- rat
- Strain:
- other: CFE strain
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Details on test animal
TEST ANIMALS
- Source: specified-pathogen free breeding colony
- Age at study initiation: No data available
- Weight at study initiation:
Male: 65-100 g
Females: 60-90 g
- Fasting period before study: No data available
- Housing: They were housed five in a cage in an animal room maintained at 21 ± 1°C and 50-60% relative humidity.
- Diet (e.g. ad libitum): Spillers’ Laboratory Small Animal Diet, ad libitum
- Water (e.g. ad libitum): Water, ad libitum
- Acclimation period: No data available
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21 ± 1°C
- Humidity (%):50-60%
- Air changes (per hr): No data available
- Photoperiod (hrs dark / hrs light): No data available
IN-LIFE DATES: From: To: No data available
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Details on oral exposure:
- Details on oral exposure
PREPARATION OF DOSING SOLUTIONS: The concentrations of the solutions were selected so that each rat was given 5 ml/kg of the appropriate solution.
DIET PREPARATION
- Rate of preparation of diet (frequency): Not applicable as chemical given through oral route
- Mixing appropriate amounts with (Type of food): Not applicable
- Storage temperature of food: Not applicable
VEHICLE
- Justification for use and choice of vehicle (if other than water): Becauce of chemical volatility and low solubility in water the flavouring could not be administered to the rats in the diet or drinking-water and was given instead by daily oral intubation as a solution in corn oil.
- Concentration in vehicle: No data available
- Amount of vehicle (if gavage): 5 ml/kg
- Lot/batch no. (if required): No data available
- Purity: No data available - Analytical verification of doses or concentrations:
- not specified
- Details on analytical verification of doses or concentrations:
- No data available
- Duration of treatment / exposure:
- 15 weeks
- Frequency of treatment:
- Daily
Doses / concentrations
- Remarks:
- Doses / Concentrations:
0 (control), 10, 50 and 500 mg/kg body weight/day.
Basis:
actual ingested
- No. of animals per sex per dose:
- 15 male rats and 15 females were used.
In addition, groups of five rats of each sex were given daily doses at the same levels for 6 wk and groups of ten male and five female rats were treated for 2wk. - Control animals:
- yes
- Details on study design:
- No data available
- Positive control:
- No data available
Examinations
- Observations and examinations performed and frequency:
- Observations and examinations performed & frequency
CAGE SIDE OBSERVATIONS: No data
- Time schedule: No data
- Cage side observations checked in table [No.?] were included. No data
DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule: No data
BODY WEIGHT: Yes
- Time schedule for examinations: weekly up to wk 14
FOOD CONSUMPTION AND COMPOUND INTAKE (if feeding study):
- Food consumption for each animal determined and mean daily diet consumption calculated as g food/kg body weight/day: Yes, was determined during the 24 hr preceding each weighing.
- Compound intake calculated as time-weighted averages from the consumption and body weight gain data: No data
FOOD EFFICIENCY:
- Body weight gain in kg/food consumption in kg per unit time X 100 calculated as time-weighted averages from the consumption and body weight gain data: No data
WATER CONSUMPTION AND COMPOUND INTAKE (if drinking water study): Yes
- Time schedule for examinations: was determined during the 24 hr preceding each weighing
OPHTHALMOSCOPIC EXAMINATION: No data
- Time schedule for examinations: No data
- Dose groups that were examined: No data
HAEMATOLOGY: Yes
- Time schedule for collection of blood: At the time of autopsy.
- Anaesthetic used for blood collection: Yes
- Animals fasted: yes, the animals were deprived of food for 24 hr
- How many animals: animals mention but not exact numbers
- Parameters checked in table [No.?] were examined. Haemoglobin content packed cell volume and counts of erythrocytes and leucocytes.
CLINICAL CHEMISTRY: Yes
- Time schedule for collection of blood: At the time of autopsy
- Animals fasted: Yes, the animals were deprived of food for 24 hr
- How many animals: animals mention but not exact numbers
- Parameters checked: The serum was analysed for urea, glucose, total protein and albumin as well as for the activities of glutamic-oxalacetic transaminases, glutamic-pyruvic transaminases and lactic dehydrogenase.
URINALYSIS: Yes
- Time schedule for collection of urine: At the final week of treatment.
In addition, at wk 6 and 14, the same measurements were made on the urine produced during a 4-hr period commencing after 16 hr without water. The number of cells in the urine was counted using the 2-hr sample.
- Metabolism cages used for collection of urine: No data
- Animals fasted: No data
- Parameters checked: examined for appearance, microscopic constituents and content of albumin, glucose, ketones, bile salts and blood.
Renal concentrating and diluting ability was assessed at the same intervals by measuring the specific gravity and volume of the urine produced during a 6-hr period of water deprivation and in the 2-hr period after a water load of 25 ml/kg.
NEUROBEHAVIOURAL EXAMINATION: No data
- Time schedule for examinations: No data
- Dose groups that were examined: No data
- Battery of functions tested: No data sensory activity / grip strength / motor activity / other:
OTHER: No data - Sacrifice and pathology:
- GROSS PATHOLOGY: Yes HISTOPATHOLOGY: Yes, Samples of organs were preserved in 10% buffered formalin.
Paraffin-wax sections of these tissues were stained with haematoxylin and eosin for microscopic examination. - Other examinations:
- No data available
- Statistics:
- No data available
Results and discussion
Results of examinations
- Clinical signs:
- effects observed, treatment-related
- Description (incidence and severity):
- No deaths and no abnormalities in behaviour were seen during the study.
- Mortality:
- mortality observed, treatment-related
- Description (incidence):
- No deaths and no abnormalities in behaviour were seen during the study.
- Body weight and weight changes:
- effects observed, treatment-related
- Food consumption and compound intake (if feeding study):
- effects observed, treatment-related
- Description (incidence and severity):
- At the highest dose level the overall food intake was slightly increased in both sexes.
- Food efficiency:
- not specified
- Water consumption and compound intake (if drinking water study):
- effects observed, treatment-related
- Ophthalmological findings:
- not specified
- Haematological findings:
- effects observed, treatment-related
- Clinical biochemistry findings:
- effects observed, treatment-related
- Description (incidence and severity):
- The results of the serum analyses were similar in test and control rats.
- Urinalysis findings:
- effects observed, treatment-related
- Behaviour (functional findings):
- not specified
- Organ weight findings including organ / body weight ratios:
- effects observed, treatment-related
- Gross pathological findings:
- effects observed, treatment-related
- Description (incidence and severity):
- At autopsy, small lung lesions were observed
- Histopathological findings: non-neoplastic:
- effects observed, treatment-related
- Description (incidence and severity):
- No histological changes related to the period or level of treatment was seen in any of the organs examined.
- Histopathological findings: neoplastic:
- not specified
- Details on results:
- Body weight and weight gain:
The males given two highest levels of hydratropic aldehyde gained slightly less weight than the controls. The differences were not statistically signific
ant. No differences between treated and control groups were detected in the male rats given 10 mg/kg/day or in the females at any dose level.
Water consumption and compound intake:
The overall water intake in the group 10 mg/kg/day were increased by 15 and 21%, compared with the controls, in males and females. In the males the differences in water intake between treated and control groups were statistically significant only at 28. 41, and 56 days.
Haematology:
The haemoglobin concentration was decreased by 5-7% compared with the controls in the males given 500 mg hydratropic aldehyde/kg/day at wk 6 and in both sexes at wk 15, It was decreased by a similar amount in the females given 50 mg/kg/day for 15 wk and the decreases in haemoglobin concentration at the higher dosage levels after 6 and 15 wk were probably related to treatment..
Urinanalysis:
The urine of all the rats was free from bile, blood, glucose and ketones and the concentrations of albumin were similar in all groups. The renal concentration, cell excretion rates and dilution tests showed no statistically significant differences between treated and control animals.
Organ weights:
Increases in the weights of several organs, notably the liver, kidney and stomach in animals treated with the highest dose level of 500 mg/kg/day.
There were increases in relative liver weight at the lower dose levels these were confined to the males at wk 15. The liver weight was increased in animals receiving 500 mg/kg/day, without any histopathological change. Slight increases in relative liver weight were noted with 10 and 50 mg/kg/day, but these were not considered to be related to treatment.
Effect levels
- Dose descriptor:
- NOAEL
- Effect level:
- 10 mg/kg bw/day (actual dose received)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: Clinical signs and mortality, Histopathology, organ weight
Target system / organ toxicity
- Critical effects observed:
- not specified
Applicant's summary and conclusion
- Conclusions:
- The endpoint for the repeated dose toxicity was found to be NOAEL at 10 mg/kg/day for rat when treated with Hydratropic aldehyde (93-53-8).
- Executive summary:
Repeated dose toxicity test was performed on rats for 15 weeks with different concentrations as 0 (control), 10, 50 or 500 mg/kg body weight/day. Rats of CFE strain were used and given Spillers’ Laboratory Small Animal Diet and waterad lib. 15 male and female rats per dose were given daily oral intubation of hydratropic aldehyde of different concentrations where corn oil is used as a vehicle. The rats were weighed weekly up to wk 14 and the consumption of food and water was determined during the 24 hr preceding each weighing. On the day after the final dose, the animals were deprived of food for 24 hr and killed by exsanguination from the aorta under barbiturate anaesthesia and the blood was used for haematological examinations and serum analyses. Gross and histopathology were done. Urine was collected during the final week of treatment and examined for appearance, microscopic constituents and content of albumin, glucose, ketones, bile salts and blood.Slight increases in relative liver weight were noted with 10 and 50 mg/kg/day, but these were not considered to be related to treatment. There were statistically significant increases in water consumption at the highest dose level and small reductions in haemoglobin concentration in rats given 50 or 500 mg/kg/day.The histological appearance of all tissues was similar in the test and control groups.
Therefore, endpoint for the repeated dose toxicity was found to be NOAEL at 10 mg/kg/day for rat when treated with Hydratropic aldehyde (93-53-8).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.